Conditional knockdown of tubedown-1 in endothelial cells leads to neovascular retinopathy.

作者: Dana S. Wall , Robert L. Gendron , William V. Good , Ewa Miskiewicz , Mandy Woodland

DOI: 10.1167/IOVS.03-1410

关键词: Diabetic retinopathyNeovascularizationRetinalEndothelial stem cellBiologyPathologyRetinopathyEndotheliumChoroidal neovascularizationRetina

摘要: Purpose Identification of novel proteins involved in retinal neovascularization may facilitate new and more effective molecular-based treatments for proliferative retinopathy. Tubedown-1 (Tbdn-1) is a protein that shows homology to the yeast acetyltransferase subunit NAT1 copurifies with an activity. Tbdn-1 expressed normal endothelium but specifically suppressed endothelial cells from patients diabetic The purpose this study was investigate importance expression blood vessels vivo. Methods A bitransgenic mouse model enables conditional knockdown produced studied using molecular, histologic, immunohistochemical techniques morphometric analysis. Results Tbdn-1-suppressed mice exhibited choroidal intra- preretinal fibrovascular lesions similar human retinopathies. Retinal observed increased severity prolonged suppression Tbdn-1. In comparison retina, displayed alterations basement membrane distribution glial myofibroblastic cells. Moreover, pathologic consequences were restricted retina choroid. Conclusions These results indicate maintenance important vessel homeostasis controlling adults. Restoration and/or activity provide approach treating

参考文章(50)
J Stone, Y Zhang, Role of astrocytes in the control of developing retinal vessels. Investigative Ophthalmology & Visual Science. ,vol. 38, pp. 1653- 1666 ,(1997)
Peter A. Campochiaro, Gregg L. Semenza, Donald J. Zack, Sean F. Hackett, Hiroaki Ozaki, Jose D. Luna, Aimee Y. Yu, Naoyuki Okamoto, Neil Della, Haruhiko Yamada, Keiko Ozaki, Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Investigative Ophthalmology & Visual Science. ,vol. 40, pp. 182- 189 ,(1999)
William V. Good, Robert L. Gendron, Lisa C. Adams, Hélène Paradis, Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy. Investigative Ophthalmology & Visual Science. ,vol. 42, pp. 3000- 3007 ,(2001)
A Gaudric, M Paques, P Massin, Growth factors and diabetic retinopathy Diabetes & Metabolism. ,vol. 23, pp. 125- 130 ,(1997)
Nancy L. Derevjanik, Peter A. Campochiaro, Melissa A. Vinores, Stanley A. Vinores, Donald J. Zack, Naoyuki Okamoto, Takao Tobe, Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Investigative Ophthalmology & Visual Science. ,vol. 39, pp. 180- 188 ,(1998)
Dean Eliott, James E. Puklin, Rajesh H. Amin, Gary W. Abrams, Alexander Kennedy, Robert N. Frank, Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Investigative Ophthalmology & Visual Science. ,vol. 38, pp. 36- 47 ,(1997)
Giulio Gabbiani, Marie-Luce Bochaton-Piallat, Mireille Redard, Anastasios D. Kapetanios, Guy Donati, Constantin J. Pournaras, TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Investigative Ophthalmology & Visual Science. ,vol. 41, pp. 2336- 2342 ,(2000)
Dosso Aa, Rungger-Brändle E, Leuenberger Pm, Glial reactivity, an early feature of diabetic retinopathy. Investigative Ophthalmology & Visual Science. ,vol. 41, pp. 1971- 1980 ,(2000)